CAS: 858134-23-3

Vialinin A is an analog of the natural product vialinin B that has been expressed in E. coli as a recombinant protein. Vialinin A inhibits the ubiquitination of proteins, which prevents cell death by inhibiting the degradation of proteins through proteasome-dependent pathways. This leads to activation of pro-survival pathways and inhibition of apoptosis. Vialinin A also has antiangiogenic properties, which may be due to its ability to inhibit endothelial cell proliferation and migration. In addition, this compound also has anti-inflammatory properties and can inhibit the production of inflammatory cytokines such as IL-1β and TNF-α. Vialinin A is able to bind to monoclonal antibodies with high affinity, making it a potential therapeutic agent for cancer treatments. The logarithmic growth phase (G2) is characterized by DNA replication and mitosis, which are inhibited by Vialinin A treatment in

Vialinin A, a p-terphenyl with antioxidant properties, inhibits TNF-α/USP4/5/SENP1, used in autoimmune/cancer research.